Current status of thrombolytics-the need for better, especially safer, agents

Thrombosis Research
Gilbert C White

Abstract

Clot dissolution using enzymes from the human fibrinolytic system has long been a goal of physicians and scientists. While recent focus has been on activators of the fibrinolytic system, new data support the use of plasmin itself. This supplement reviews the role of plasmin in fibrinolysis and locally administered plasmin as a safe and effective therapeutic.

References

Jan 15, 2003·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·F J I FowkesF G R Fowkes
Jun 20, 2003·Circulation·Richard H White
Jul 1, 1959·The Journal of Clinical Investigation·N ALKJAERSIGS SHERRY
Dec 30, 2006·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

May 24, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Rita K UpmacisDavid P Hajjar
Apr 24, 2019·Journal of Biomedical Materials Research. Part a·Mengjie HuangYanzheng Ji
Jun 16, 2012·Health Economics·Isabel Günther, Youdi Schipper
Jul 3, 2019·The American Journal of Tropical Medicine and Hygiene·Abigail E BrayGeorge J Fuchs
May 2, 2014·Tropical Medicine & International Health : TM & IH·Annette Prüss-UstünSandy Cairncross
Sep 24, 2018·Journal of Applied Microbiology·C García-AljaroF Lucena

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.